investorscraft@gmail.com

Intrinsic ValueHealthcare Special Opportunities Fund (MDS-UN.TO)

Previous Close$11.26
Intrinsic Value
Upside potential
Previous Close
$11.26

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Healthcare Special Opportunities Fund is a closed-ended balanced mutual fund focused on the medical and healthcare sectors, managed by LDIC Inc. The fund employs a dual strategy of investing in public equity and fixed income within developed markets, targeting mid- and small-cap growth stocks. Its investment approach combines fundamental and quantitative analysis, leveraging both top-down macroeconomic insights and bottom-up stock selection to optimize portfolio performance. Benchmarking against the MSCI World Healthcare Index, the fund emphasizes in-house research to identify high-potential opportunities in a sector known for its resilience and innovation. The healthcare sector's defensive characteristics and long-term growth prospects provide a stable foundation for the fund's strategy. With a niche focus on healthcare, the fund differentiates itself from broader asset managers, catering to investors seeking targeted exposure to this high-growth industry.

Revenue Profitability And Efficiency

In FY 2023, the fund reported revenue of CAD 716,974 and net income of CAD 437,261, reflecting a healthy profit margin. The diluted EPS stood at CAD 0.18, indicating modest but positive earnings per share. Operating cash flow was robust at CAD 1,110,731, with no capital expenditures, suggesting efficient cash management and a focus on liquidity.

Earnings Power And Capital Efficiency

The fund's earnings power is supported by its ability to generate consistent net income and strong operating cash flow. With no debt and CAD 347,376 in cash and equivalents, the fund maintains a conservative capital structure, allowing for flexibility in investment decisions. The absence of leverage underscores a disciplined approach to risk management.

Balance Sheet And Financial Health

The fund's balance sheet is characterized by a debt-free position and solid liquidity, with cash and equivalents covering operational needs. Total assets are primarily composed of equity and fixed-income investments, aligned with its mandate. The financial health appears stable, with no significant liabilities and a focus on preserving capital while seeking growth opportunities.

Growth Trends And Dividend Policy

The fund's growth is tied to the performance of the healthcare sector, which has shown resilience and innovation-driven expansion. A dividend of CAD 0.27074 per share reflects a commitment to returning capital to shareholders, though the yield should be evaluated in the context of the fund's total return strategy. Future growth will depend on sector trends and the fund's ability to identify winning investments.

Valuation And Market Expectations

With a market cap of CAD 19.1 million, the fund is a small player in the asset management space. The lack of beta data suggests low correlation with broader markets, potentially appealing to investors seeking sector-specific exposure. Valuation metrics should be assessed relative to healthcare-focused peers and the fund's historical performance.

Strategic Advantages And Outlook

The fund's strategic advantage lies in its specialized focus on healthcare, a sector with enduring demand and innovation potential. Its research-driven approach and conservative financial posture position it well for long-term growth. However, its small size may limit scalability. The outlook depends on healthcare sector dynamics and the fund's ability to capitalize on emerging opportunities.

Sources

Fund description and financial data sourced from publicly available disclosures and TSX listings.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount